---
figid: PMC5209623__OMCL2016-7205747.002
figlink: /pmc/articles/PMC5209623/figure/fig2/
number: F2
caption: The proposed AD therapeutic approaches targeting NO pathway. (A) Vaccines
  and agents that could clear β-amyloid proteins. (B) Calcium channel blockers. (C)
  Molecules that can increase bioavailability of NO such as NO mimetics. (D) Antioxidants.
  (E) iNOS inhibitor.
pmcid: PMC5209623
papertitle: 'Nitric Oxide: Exploring the Contextual Link with Alzheimer''s Disease.'
reftext: Nicholas Asiimwe, et al. Oxid Med Cell Longev. 2016;2016:7205747.
pmc_ranked_result_index: '115798'
pathway_score: 0.91026
filename: OMCL2016-7205747.002.jpg
figtitle: The proposed AD therapeutic approaches targeting NO pathway
year: '2016'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5209623__OMCL2016-7205747.002.html
  '@type': Dataset
  description: The proposed AD therapeutic approaches targeting NO pathway. (A) Vaccines
    and agents that could clear β-amyloid proteins. (B) Calcium channel blockers.
    (C) Molecules that can increase bioavailability of NO such as NO mimetics. (D)
    Antioxidants. (E) iNOS inhibitor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNF
  - IL6
  - NOS1
  - ASS1
genes:
- word: IL-6,TNF-a
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: IL-6,TNF-a
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: NNOS
  symbol: nNOS
  source: hgnc_alias_symbol
  hgnc_symbol: NOS1
  entrez: '4842'
- word: Aß
  symbol: ASS
  source: hgnc_prev_symbol
  hgnc_symbol: ASS1
  entrez: '445'
chemicals: []
diseases: []
figid_alias: PMC5209623__F2
redirect_from: /figures/PMC5209623__F2
figtype: Figure
---
